This document is an excerpt from the EUR-Lex website
Document 62020TB0633
Case T-633/20: Order of the General Court of 27 September 2021 — CNMSE and Others v Parliament and Council (Action for annulment — Public health — Regulation (EU) 2020/1043 — Conduct of clinical trials with medicinal products for human use containing GMOs — Treatment or prevention of the coronavirus disease SARS-CoV-2 (COVID-19) — Concept of legislative act — Concept of regulatory act — No individual concern — Inadmissibility)
Case T-633/20: Order of the General Court of 27 September 2021 — CNMSE and Others v Parliament and Council (Action for annulment — Public health — Regulation (EU) 2020/1043 — Conduct of clinical trials with medicinal products for human use containing GMOs — Treatment or prevention of the coronavirus disease SARS-CoV-2 (COVID-19) — Concept of legislative act — Concept of regulatory act — No individual concern — Inadmissibility)
Case T-633/20: Order of the General Court of 27 September 2021 — CNMSE and Others v Parliament and Council (Action for annulment — Public health — Regulation (EU) 2020/1043 — Conduct of clinical trials with medicinal products for human use containing GMOs — Treatment or prevention of the coronavirus disease SARS-CoV-2 (COVID-19) — Concept of legislative act — Concept of regulatory act — No individual concern — Inadmissibility)
OJ C 490, 6.12.2021, p. 43–43
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
6.12.2021 |
EN |
Official Journal of the European Union |
C 490/43 |
Order of the General Court of 27 September 2021 — CNMSE and Others v Parliament and Council
(Case T-633/20) (1)
(Action for annulment - Public health - Regulation (EU) 2020/1043 - Conduct of clinical trials with medicinal products for human use containing GMOs - Treatment or prevention of the coronavirus disease SARS-CoV-2 (COVID-19) - Concept of legislative act - Concept of regulatory act - No individual concern - Inadmissibility)
(2021/C 490/51)
Language of the case: French
Parties
Applicants: Coordination nationale médicale santé — environnement (CNMSE) (Paris, France) and the five other applicants whose names are listed in the annex to the order (represented by: G. Tumerelle, lawyer)
Defendants: European Parliament (represented by: J. Etienne and W. Kuzmienko, acting as Agents), Council of the European Union (represented by: A. Jaume and M. Moore, acting as Agents)
Re:
Application based on Article 263 TFEU seeking annulment of Regulation (EU) 2020/1043 of the European Parliament and of the Council of 15 July 2020 on the conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease (COVID-19) (OJ 2020 L 231, p. 12).
Operative part of the order
|
1. |
The action is dismissed as inadmissible. |
|
2. |
There is no longer any need to adjudicate on the applications to intervene submitted by the European Commission and the non-profit-making association ‘Groupe de Réflexion et d’Action Pour une Politique Ecologique’. |
|
3. |
The Coordination nationale médicale santé — environnement (CNMSE) and the other applicants whose names are listed in the annex shall bear their own costs and those incurred by the European Parliament and the Council of the European Union. |
|
4. |
The Commission and the non-profit-making association ‘Groupe de Réflexion et d’Action Pour une Politique Ecologique’ shall bear the costs relating to their respective applications to intervene. |